What is the BUD date of a solid repackaged drug?

The BUD, or Beyond Use Date, for a solid repackaged drug is based on a guideline that prioritizes safety and efficacy. This date is determined to ensure that the medication remains effective and does not pose a risk to patients over time. In practice, the guideline states that the BUD for a repackaged solid drug is set to one year after the drug has been repackaged or at the manufacturer's expiration date, whichever comes first.

This means that if a manufacturer labels a drug with an expiration date of six months from the time of production, and the pharmacy repackages it, the BUD would be limited to that six-month expiration date, ensuring that the medication is not used beyond the date deemed safe by the manufacturer. Conversely, if the drug has an expiration date of two years and is repackaged, the BUD would be set for one year from the date of repackaging since that is the shorter duration.

This principle is important in pharmacy practice to minimize the risk of administering ineffective or potentially harmful medications to patients.